Log In
BCIQ
Print this Print this
 

Farnesoid X receptor (FXR) (NR1H4)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Farnesoid X receptor (FXR) (NR1H4)

BCIQ
Print ChartPrint this
Registration, 1 Phase III, 1 Phase II, 2 Phase II, 1 Phase II, 1 Phase I, 1 Phase I, 1 Preclinical, 1 Preclinical, 1
Phase of DevelopmentPreclinicalPhase IPhase IIPhase IIIRegistration
Endocrine / Metabolic

1

-

1

-

-

Gastrointestinal

-

-

1

-

-

Hepatic

-

1

2

1

1

Infectious

1

-

-

-

-

Renal

-

1

-

-

-




 Products Targeting Farnesoid X receptor (FXR) (NR1H4)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

3

$315.0M

$15.0M

$770.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today